Nautilus Biotechnology (NAUT) Short-term Investments (2020 - 2026)

Nautilus Biotechnology (NAUT) has 7 years of Short-term Investments data on file, last reported at $81.2 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments fell 23.04% year-over-year to $81.2 million; the trailing twelve-month figure through Mar 2026 stood at $81.2 million (down 23.04% YoY), and the FY2025 full-year result was $91.0 million, down 10.98% from the prior year.
• Short-term Investments slipped to $81.2 million in Q1 2026, from $91.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $155.6 million in Q1 2024 to a low of $69.0 million in Q3 2022.
• A 5-year average of $107.8 million and a median of $105.6 million in 2025 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments sank 56.31% in 2022 and jumped 120.19% in 2023, its largest moves.
• Tracing NAUT's Short-term Investments over 5 years: stood at $69.9 million in 2022, then jumped by 120.19% to $154.0 million in 2023, then tumbled by 33.61% to $102.2 million in 2024, then declined by 10.98% to $91.0 million in 2025, then retreated by 10.74% to $81.2 million in 2026.
• Business Quant data shows NAUT's Short-term Investments at $81.2 million in Q1 2026, $91.0 million in Q4 2025, and $107.6 million in Q3 2025.